Most studies performed in vivo in Pparα-null mice have suggested that the mechanisms by which PPARα protects from steatosis and NASH involve its ability to transactivate genes required for fatty acid catabolism38 and to repress a number of inflammatory genes39,41. The gene discussed is PPARA; the disease is metabolic dysfunction-associated steatohepatitis.